What are the P/E ratios of REGN and AMGN?

REGN trades at a price-to-earnings ratio (TTM) of 19.1, compared with 23.3 for AMGN.

How do REGN and AMGN compare on revenue?

REGN reported revenue of $15.53B (TTM), while AMGN reported $38.09B (TTM).

REGN's net income was $4.33B (TTM), versus $8.74B (TTM) for AMGN.

REGN's diluted earnings per share is $40.41, compared with $16.10 for AMGN.

REGN and AMGN side by side — valuation & fundamentals (public data).

REGN vs AMGN key statistics
Metric	REGNREGENERON PHARMACEUTICALS, INC.	AMGNAmgen Inc.
Market cap	—	$203.14B
P/E (TTM)	19.1	23.3
P/B	—	17.38
P/S	—	5.5x
Dividend yield	—	2.52%
Revenue	$15.53B(TTM)	$38.09B(TTM)
Revenue growth (YoY)	1.0%	10.0%
Net income	$4.33B(TTM)	$8.74B(TTM)
Earnings growth (YoY)	2.1%	88.5%
EPS, diluted	$40.41(TTM)	$16.10(TTM)
EBIT margin	24.9%	24.7%
ROE	14.2%	66.0%
ROIC	9.4%	15.1%
1y total return	+35.0%	+40.3%

Figures from SEC filings · for reference only · not investment advice

Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)